MedTrix Healthcare plans to foray into US, EU markets

Digital and medical communications solutions provider MedTrix Healthcare plans to foray into the US and European Union (EU) markets to expand its operations following its tie-up with leading pharma companies.

"We are planning to expand into multiple geographies by increasing our access to the top pharma firms and doubling the headcount," the city-based company said in a statement here on Sunday.

The pharma sector is at its experimental phase in developing and deploying digital health solutions aimed at reaching HCPs (healthcare common procedures) and patients to improve disease outcomes.

"Digital solutions are expected to result in 7-11 percent savings in total healthcare spending," MedTrix founder and director Vimal Narayanan said.

The HCP codes are based on the American Medical Association's current procedural terminology.

Among the company's global pharma clientele are Novartis, Bayer, Nestle, Eli Lilly, Pfizer, and Amgen. The company has also entered into strategic agreements with key clients in the US and EU markets to expand its footprint worldwide.

"Until recently, though we have been engaging with some key clients in many projects in developed markets, most were in a pilot phase. Many of them have gone on to achieve successful metrics, prompting them to provide us with larger engagements," Narayanan noted.

As a driver of the paradigm shifts in the pharma industry, the company plans engagements for professionals through digital route and production of digital assets for communications like apps, websites, videos and social media support.

"With 6.9-billion dollar investments in digital solutions by global healthcare and pharma industry in 2015, we have begun to offer a berth for India in the growing space for others to follow," Narayanan added.

The company also provides support to conceptualize, develop and launch new technologies to benefit patients and healthcare providers with measured return on investment.